Widiapradja Alexander, Chunduri Prasad, Levick Scott P
Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI, USA.
Cell Mol Life Sci. 2017 Jun;74(11):2019-2038. doi: 10.1007/s00018-017-2452-x. Epub 2017 Jan 17.
In addition to traditional neurotransmitters of the sympathetic and parasympathetic nervous systems, the heart also contains numerous neuropeptides. These neuropeptides not only modulate the effects of neurotransmitters, but also have independent effects on cardiac function. While in most cases the physiological actions of these neuropeptides are well defined, their contributions to cardiac pathology are less appreciated. Some neuropeptides are cardioprotective, some promote adverse cardiac remodeling and heart failure, and in the case of others their functions are unclear. Some have both cardioprotective and adverse effects depending on the specific cardiac pathology and progression of that pathology. In this review, we briefly describe the actions of several neuropeptides on normal cardiac physiology, before describing in more detail their role in adverse cardiac remodeling and heart failure. It is our goal to bring more focus toward understanding the contribution of neuropeptides to the pathogenesis of heart failure, and to consider them as potential therapeutic targets.
除了交感神经系统和副交感神经系统的传统神经递质外,心脏还含有多种神经肽。这些神经肽不仅能调节神经递质的作用,还对心脏功能有独立影响。虽然在大多数情况下这些神经肽的生理作用已得到明确界定,但它们对心脏病理的贡献却较少受到重视。一些神经肽具有心脏保护作用,一些会促进不良心脏重塑和心力衰竭,还有一些神经肽的功能尚不清楚。有些神经肽根据特定的心脏病理情况及其进展,兼具心脏保护作用和不良影响。在本综述中,我们先简要描述几种神经肽对正常心脏生理的作用,然后更详细地阐述它们在不良心脏重塑和心力衰竭中的作用。我们的目标是更加关注了解神经肽对心力衰竭发病机制的贡献,并将它们视为潜在的治疗靶点。